The present disclosure relates to an immunostimulatory combination comprising a therapeutic vaccine and a PD-1-related blockade for treating human papillomavirus (HPV) associated diseases. The combination generates a more potent response against HPV-associate diseases by stimulating the immune response of immune cells.